Congress trades

Organon & Co. (OGN)

NYSE · Healthcare · 43 congress trades · last filed 1 month ago

20
Congress disclosures shown
29d
Median delay on the congress disclosures
of the 45 day limit
3/17
Purchases and sales in the disclosures shown

About Organon & Co.

from the company's filings and listing
Exchange
NYSE
Sector
Healthcare
Industry
Drug Manufacturers - General
Chief executive
Joseph T. Morrissey Jr.
Employees
10,000
Listed since
May 14, 2021
Market value
$3.6B
Price to earnings
17.3
Earnings per share
$0.80
Dividend yield
0.59%

www.organon.com

Earnings

6 reported quarters · next on Nov 9, 2026
QuarterEPSEPS expectedRevenueRevenue expectedResult
Q2 FY2026reported Jul 31, 2026$0.85$0.85$1.6B$1.6BEPS in lineRevenue in line
Q1 FY2026reported Apr 30, 2026$0.71$0.83$1.5B$1.5BEPS missRevenue miss
Feb 12, 2026$0.63$0.73$1.5B$1.5BEPS missRevenue miss
Q3 FY2025reported Nov 10, 2025$1.01$0.93$1.6B$1.5BEPS beatRevenue beat
Q2 FY2025reported Aug 5, 2025$1.00$0.94$1.6B$1.6BEPS beatRevenue beat
Q1 FY2025reported May 1, 2025$1.02$0.89$1.5B$1.5BEPS beatRevenue miss

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.

Executive pay

as filed for 2025 · proxy filed Apr 24, 2026
ExecutiveSalaryStock awardsOtherTotal
Joseph MorrisseyInterim Chief Executive Officer$819K$3.4M$1.6M$5.8M
Matthew WalshEVP and Chief Financial Officer$919K$3.0M$1.7M$5.7M
Juan Camilo Arjona FerreiraM.D. EVP and Head of R&D and Chief Medical Officer$735K$1.9M$1.2M$3.8M
Rachel StahlerEVP and Chief Digital$707K$1.7M$1.1M$3.6M
Kirke WeaverEVP, General Counsel and Corporate Secretary$677K$1.7M$1.1M$3.5M

The summary compensation table from the 2025 proxy statement, current executives only. 1 executive who has since left the company is named in that filing and not shown here. Read the filing

Institutional holders

13F positions as of Jun 30, 2026
HolderValueSharesChangeOf company
Blackrock, Inc.$434.0M32,056,866+1.1%12.21%
Pentwater Capital Management LP$245.1M18,100,000+100.0%6.89%
Vanguard Portfolio Management LLC$204.9M15,132,118-30.7%5.76%
Vanguard Capital Management LLC$161.3M11,909,865+1.5%4.54%
State Street Corp$130.8M9,659,371-3.0%3.68%
Goldman Sachs Group Inc$70.4M5,199,002+223.9%1.98%
UBS Group AG$65.8M4,856,529+39.9%1.85%
Geode Capital Management, LLC$65.2M4,815,610+1.2%1.83%
MAN Group PLC$56.6M4,180,500+100.0%1.59%
AQR Arbitrage LLC$52.4M3,880,354+100.0%1.48%
Private Management Group Inc$50.7M3,742,161-14.4%1.43%
LSV Asset Management$50.6M3,737,036-48.5%1.42%

A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.

Know the moment the next OGN filing lands.

GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.

Congress trades in OGN

20 disclosures of 43 on record · median 29d of the 45 allowed
MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Kevin HernJointStockSale$1,001 - $15,000+0.7%S&P -0.9% · vs S&P 500 +1.7%Aug 5, 2026Aug 10, 20265d
Gary C. PetersSelfFiled lateStockSale (Full)$1,001 - $15,000+36.4%S&P +21.8% · vs S&P 500 +14.6%Jul 10, 2025Nov 24, 2025137d
Ro KhannaStockSale$1,001 - $15,000+15.6%S&P +67.0% · vs S&P 500 -51.4%Dec 4, 2023Jan 4, 202431d
Ro KhannaStockSale$1,001 - $15,000+2.8%S&P +75.5% · vs S&P 500 -72.7%Nov 3, 2023Dec 6, 202333d
Ro KhannaStockPurchase$1,001 - $15,000-17.6%S&P +79.3% · vs S&P 500 -96.9%Oct 2, 2023Nov 8, 202337d
Ro KhannaStockSale$1,001 - $15,000-38.4%S&P +66.9% · vs S&P 500 -105.3%Jul 28, 2023Aug 7, 202310d
Ro KhannaStockPurchase$1,001 - $15,000-34.1%S&P +74.1% · vs S&P 500 -108.2%Jun 29, 2023Jul 11, 202312d
Ro KhannaStockSale$1,001 - $15,000-32.7%S&P +83.1% · vs S&P 500 -115.8%May 19, 2023Jun 12, 202324d
Ro KhannaStockPurchase$1,001 - $15,000-41.7%S&P +88.7% · vs S&P 500 -130.4%Apr 25, 2023May 8, 202313d
Michael T. McCaulStockSale$15,001 - $50,000-52.2%S&P +95.7% · vs S&P 500 -148.0%Sep 15, 2022Oct 13, 202228d
Michael T. McCaulStockSale$1,001 - $15,000-47.8%S&P +103.3% · vs S&P 500 -151.0%Sep 22, 2022Oct 13, 202221d
Michael T. McCaulStockSale$15,001 - $50,000-52.0%S&P +93.5% · vs S&P 500 -145.5%Sep 14, 2022Oct 13, 202229d
Michael T. McCaulStockSale$1,001 - $15,000-54.0%S&P +87.8% · vs S&P 500 -141.8%Sep 9, 2022Oct 13, 202234d
Michael T. McCaulStockSale$15,001 - $50,000-54.0%S&P +87.8% · vs S&P 500 -141.8%Sep 9, 2022Oct 13, 202234d
Michael T. McCaulStockSale$50,001 - $100,000-52.2%S&P +94.3% · vs S&P 500 -146.5%Sep 13, 2022Oct 13, 202230d
Michael T. McCaulStockSale$15,001 - $50,000-47.8%S&P +103.3% · vs S&P 500 -151.0%Sep 22, 2022Oct 13, 202221d
Michael T. McCaulStockSale$15,001 - $50,000-48.8%S&P +101.5% · vs S&P 500 -150.3%Sep 21, 2022Oct 13, 202222d
Michael T. McCaulStockSale$15,001 - $50,000-52.2%S&P +94.3% · vs S&P 500 -146.5%Sep 13, 2022Oct 13, 202230d
Michael T. McCaulStockSale$50,001 - $100,000-52.0%S&P +93.5% · vs S&P 500 -145.5%Sep 14, 2022Oct 13, 202229d
Michael T. McCaulStockSale$1,001 - $15,000-52.1%S&P +97.4% · vs S&P 500 -149.5%Sep 15, 2022Oct 13, 202228d

Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.

Members of Congress reporting a position

1 member · estimate, as of Sep 10, 2026

1 member reports a position (estimated). The largest estimated position is in the $1,001 - $15,000 band.

MemberParty, chamberEstimated positionShare of their portfolio
Kevin HernRepublican · House$1,001 - $15,000<0.1%

A further 1 member reports a position estimated under $1,000; those are not listed.

Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.

Questions

Which members of Congress have traded OGN?

Kevin Hern, Gary C. Peters, Ro Khanna, Michael T. McCaul disclosed OGN transactions in the filings shown here.

Which members of Congress hold OGN?

1 member of Congress reports a position in OGN in the estimate we hold as of Sep 10, 2026. The largest estimated position belongs to Kevin Hern. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.

How quickly are OGN trades disclosed?

Congressional disclosures took a median of 29 days, against the 45 the STOCK Act allows.

How to read a STOCK Act filing

WHAT THE FILING ACTUALLY SAYS

$A range, not an amount. Members disclose a band such as $1,001 to $15,000. The band is the filing, and we do not narrow it.
45Up to 45 days late, lawfully. The delay column counts calendar days from the transaction to its publication. Inside 45 days is within the law.
OPAn option names the underlying. A contract on a company is described using that company's name, so it can read like a share purchase. Those rows say otherwise.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

Data as of Sep 10, 2026.

Related companies

traded by the same members

See every company we track